Pathological and Nuclear Medicine Factors for Prognosis in Lung Carcinoma
Condition: NSCLC Intervention: Other: Clinical routine F18-FDG-PET/CT, molecular pathology and clinical outcome Sponsors: Klinikum Bayreuth GmbH; Beijing Cancer Hospital; Sana Klinikum Hof Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Carcinoma | Hospitals | Non-Small Cell Lung Cancer | Nuclear Medicine | Pathology | Research